High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation (Q79686756)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 January 2007

Language	Label	Description	Also known as
English	High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation	scientific article published on 29 January 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

stem cell transplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

El-Cheikh J

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Faucher C

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Fürst S

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Duran S

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Berger P

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Vey N

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Stoppa AM

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Bouabdallah R

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Gastaut JA

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Viens P

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Blaise D

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Mohty M

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

29 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

39

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

301-306

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17262059%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705592

0 references

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome) in beagle dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): a 91-day study in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-dose AmBisome (Liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705592

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79686756&oldid=1820152923"